X

Trial Profile

An Efficacy Study of Esomeprazole in Patients with Reflux Esophagitis Poorly Responsive to Lansoprazole

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 26 Aug 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Esomeprazole (Primary) ; Rabeprazole
Indications Reflux oesophagitis
Focus Therapeutic Use
Acronyms CHANGE-L

Most Recent Events

06 Aug 2014 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
11 Mar 2014 Planned End Date changed from 31 Aug 2014 to 31 Jul 2014 as reported by University Hospital Medical Information Network - Japan record.
25 Jan 2013 Planned end date (31 Aug 2014) added as reported by University Hospital Medical Information Network - Japan record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com